Effects of AFO Use on Walking in Boys With Duchenne Muscular Dystrophy: A Pilot Study

被引:12
作者
Townsend, Elise L. [1 ,2 ]
Tamhane, Himani [4 ]
Gross, K. Douglas [1 ,3 ]
机构
[1] MGH Inst Hlth Profess, Sch Hlth & Rehabilitat Sci, Dept Phys Therapy, Boston, MA 02129 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Boston Univ, Sch Med, Boston, MA 02118 USA
[4] Hlth East Med Ctr, Englewood, NJ USA
关键词
child; Duchenne muscular dystrophy; foot orthoses; gait; male; physical endurance; walking; CORTICOSTEROID TREATMENT; PREDNISONE; THERAPY; TRIAL;
D O I
10.1097/PEP.0000000000000099
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Purpose: Although bracing in the late ambulatory stage of Duchenne muscular dystrophy (DMD) has been described, the effects of ankle-foot orthoses (AFOs) in earlier stages have not been evaluated. The aim of this pilot study was to describe the effects of dynamic response AFO (DR-AFO) use in boys with DMD who are ambulatory. Methods: Using a crossover design, 3 boys were randomly assigned to either a 2-week DR-AFO or a placebo intervention. Phases were separated by a 1-week washout period. Primary outcomes were time to walk 10 m and a 6-Minute Walk Test. Results: With DR-AFO use, declines in 10-m walk time (median decline = 0.8 s) and 6-Minute Walk Distance (median = 25.0 m) occurred. Parental report suggested that the use of DR-AFOs increased falls in 2 of 3 participants. Conclusion: This pilot study does not support the use of DR-AFOs by boys with DMD who are ambulatory.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 32 条
[1]   The effects of knee-ankle-foot orthoses in the treatment of Duchenne muscular dystrophy: review of the literature [J].
Bakker, JPJ ;
de Groot, IJM ;
Beckerman, H ;
de Jong, BA ;
Lankhorst, GJ .
CLINICAL REHABILITATION, 2000, 14 (04) :343-359
[2]   Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy - Long-term effect [J].
Balaban, B ;
Matthews, DJ ;
Clayton, GH ;
Carry, T .
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2005, 84 (11) :843-850
[3]   Intermittent prednisone therapy in Duchenne muscular dystrophy - A randomized controlled trial [J].
Beenakker, EAC ;
Fock, JM ;
Van Tol, MJ ;
Maurits, NM ;
Koopman, HM ;
Brouwer, OF ;
Van der Hoeven, JH .
ARCHIVES OF NEUROLOGY, 2005, 62 (01) :128-132
[4]  
Bushby K., 2005, Curr. Paediatr, V15, P292, DOI [DOI 10.1016/J.CUPE.2005.04.001, 10.1016/j.cupe.2005.04.001.4D]
[5]  
Bushby Kate, 2011, Clin Investig (Lond), V1, P1217
[6]   Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care [J].
Bushby, Katharine ;
Finkel, Richard ;
Birnkrant, David J. ;
Case, Laura E. ;
Clemens, Paula R. ;
Cripe, Linda ;
Kaul, Ajay ;
Kinnett, Kathi ;
McDonald, Craig ;
Pandya, Shree ;
Poysky, James ;
Shapiro, Frederic ;
Tomezsko, Jean ;
Constantin, Carolyn .
LANCET NEUROLOGY, 2010, 9 (02) :177-189
[7]  
Case L, 2006, PAR PROJ MUSC DYSTR, P1
[8]   Gait pattern in Duchenne muscular dystrophy [J].
D'Angelo, Maria Grazia ;
Berti, Matteo ;
Piccinini, Luigi ;
Romei, Marianna ;
Guglieri, Michela ;
Bonato, Sara ;
Degrate, Alessandro ;
Turconi, Anna Carla ;
Bresolin, Nereo .
GAIT & POSTURE, 2009, 29 (01) :36-41
[9]   Energy expenditure in stroke subjects walking with a carbon composite ankle foot orthosis [J].
Danielsson, A ;
Sunnerhagen, KS .
JOURNAL OF REHABILITATION MEDICINE, 2004, 36 (04) :165-168
[10]  
Dubowitz V, 2002, Eur J Paediatr Neurol, V6, P153, DOI 10.1053/ejpn.2002.0583